retatrutide phase 2 trial obesity type 2 diabetes is investigational and is not FDA approved. In TRANSCEND retatrutide phase 2 obesity trial

Understanding whether combination therapy or monotherapy suits your individual biology requires more than clinical guidelines alone

However, its important to note: Weight management can be a valuable secondary outcome for people with T2DM, as it often improves insulin sensitivity, lowers cardiovascular risk, and enhances overall metabolic health 4 , 10

While B12 supports nerve function, red blood cell formation, and energy metabolism through methylation pathways, niacinamide fuels NAD+ production, which supports mitochondrial energy production and cellular repair

For athletes, high-performers, or patients undergoing active treatment protocols whose nutritional demands may temporarily exceed what oral supplementation provides